Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.720
+0.020 (0.74%)
Aug 14, 2025, 9:27 AM - Market open
Stereotaxis Employees
Stereotaxis had 139 employees as of December 31, 2024. The number of employees increased by 17 or 13.93% compared to the previous year.
Employees
139
Change (1Y)
17
Growth (1Y)
13.93%
Revenue / Employee
$228,820
Profits / Employee
-$177,252
Market Cap
250.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
STXS News
- 5 days ago - Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Stereotaxis Reports 2025 Second Quarter Financial Results - GlobeNewsWire
- 17 days ago - Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter - GlobeNewsWire
- 22 days ago - Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 4 weeks ago - Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Stereotaxis: Recurring Revenue Inflection - Seeking Alpha
- 6 weeks ago - First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology - GlobeNewsWire
- 3 months ago - Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript - Seeking Alpha